U.S. Markets close in 5 hrs, 36 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,335.92 | 26.00 | 0.25% |
| NASDAQ | 2,138.03 | -0.41 | -0.02% |
| S&P 500 | 1,094.22 | 2.73 | 0.25% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 16.53 09:59 AM EST | |
|---|---|---|
| Day High | 16.73 09:40 AM EST |
|
| Range | 0.20 |
| Volume | 32,930 | |
|---|---|---|
| 30-Day Avg Vol | 324,000 |
|
| Difference | -89.84% |
| Market Cap | 692.04 M | |
|---|---|---|
| Mkt Cap Chg | -9.61 M |
| Shares Out | 41.81 M | |
|---|---|---|
| % Shrs Traded | 0.08% | |
| 1yr EPS Est | -1.216 |
| 52-Wk Low | 14.82 | |
|---|---|---|
| 52-Wk High | 26.36 |
|
| Range | 11.54 |
| Prev Close | 16.78 11/27/09 | |
|---|---|---|
| Today's Open | 16.67 | |
| Change | -0.66% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 5.21 M |
| Revenue (LFY) | 96.16 M | |
|---|---|---|
| Earnings (LFY) | -26.25 M | |
| Earnings (MRQ) | -9.21 M | |
| Next Earn Est | -0.297 | |
| Next Earnings | 02/22/2010 |
|
| EPS (TTM) | -1.19 | |
| 1yr EPS Growth | -2.18% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -13.00 | |
| PEG Ratio | — | |
| Return on Equity | -13.11 | |
| Beta | 1.24 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Call it The Silence of the Genes. Alnylam Pharmaceuticals runs interference with RNA to prevent disease. RNA interference (RNAi) technology developed by the biotech firm can selectively shut off harmful ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.297 2/22/10 | — — |
—
—
|
| Last Quarter | -0.24 9/30/09 | -0.22 9/30/09 |
0.02
Beat
|
| 2 Quarters Ago | -0.488 6/30/09 | -0.55 6/30/09 |
-0.062
Missed
|
| Quarterly - 09/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 24.25 M | 96.16 M |
| Gross Profit | — | 90.44 M |
| Operating Income | -9.65 M | -27.84 M |
| Net Income | -9.21 M | -26.25 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts